Staff are encouraged to attend a presentation on Pfizer’s Centre for Therapeutic Innovation (CTI) this Thursday 28 August, 1.30-2.30pm in the MIMR-PHI Level 3 Boardrooms.Dan Grant and David Gallagher from Pfizer's Sydney office will be making a special visit to MIMR-PHI to discuss the opportunities for funding available through the CTI.
This visit follows from the recent announcement that Pfizer will establish its first CTI outside the US at Monash University.
Therapeutic areas of interest to Pfizer include:
- Inflammation
- Autoimmunity
- Tissue remodeling
- Oncology
- Cancer Immunology
- Rare or genetic diseases
- Neuroscience
- Cardiovascular
- Metabolic diseases
No comments:
Post a Comment